Périodique
Hepatitis C virus and human immunodeficiency virus-1 co-infection in former heroin addicts in methadone maintenance treatment
(Co-infection VHC - VIH 1 chez des ex-héroïnomanes en traitement de maintenance à la méthadone.)
Auteur(s) :
PICCOLO P. ;
BORG L. ;
LIN, A. ;
MELIA D. ;
HO, A. ;
KREEK, M. J.
Année
2002
Page(s) :
55-66
Langue(s) :
Anglais
Refs biblio. :
40
Domaine :
Drogues illicites / Illicit drugs
Discipline :
MAL (Maladies infectieuses / Infectious diseases)
Thésaurus mots-clés
HEROINE
;
USAGER
;
TRAITEMENT DE MAINTENANCE
;
VIH
;
HEPATITE
;
SEROPOSITIVITE
;
PREVALENCE
;
COMORBIDITE
;
EPIDEMIOLOGIE DESCRIPTIVE
Note générale :
Journal of Addictive Diseases, 2002, 21, (4), 55-66
Note de contenu :
fig.
Résumé :
ENGLISH :
Objectives: To investigate hepatitis C (HCV) and human immunodeficiency virus (HIV-1) prevalence in former opiate or heroin addicts currently in methadone maintenance treatment (MMT). Methods: Retrospective chart review for patients (n = 342) currently attending two MMT clinics affiliated with New York Presbyterian Hospital. Results: Overall seroprevalence of those tested was 67% for HCV, and 29% for HIV-1. Co-infection was present in 26% of patients. Prevalence of HCV reached 92% in the 45-49 year old group . The greatest HIV-1 prevalence (45%) was in the 35-39 year old group. There was a linear relationship between infection seroprevalence and age at admission into MMT. Conclusions: The high prevalence of HCV and HIV-1 infections in MMT patients varies both by current age and by age at admission to MMT. This population needs risk reduction education and treatment for HCV and HIV- 1. (Author' s abstract)
Affiliation :
Laboratory Biology of Addictive Diseases, The Rockefeller Univ. 1230 York Ave., New York, NY 10021. E-mail: piccolp@rockefeller.edu
Etats-Unis. United States.
Etats-Unis. United States.
Historique